Cambridge, UK, 4 April, 2025 – Abcam, a global life science company working together with researchers to advance science and enable faster breakthroughs, today announces it has been named ‘Antibody Supplier Succeeding in Genetics Research’ and highly commended in a further category in CiteAb’s prestigious annual industry awards. This is the 11th consecutive year Abcam has been recognized.

CiteAb’s ‘Antibody Supplier Succeeding in Genetics Research’ award is a brand-new category for 2025. It recognizes the importance of antibodies in genetics research, capturing data on secondary antibodies used in assays in this field as well as specific primary antibodies for targets in genetics research. Genetics research is pivotal in understanding the complexities of gene function and regulation. Techniques like spatial transcriptomics allow researchers to map gene expression within tissues, providing spatial context that is crucial for understanding cellular function and disease mechanisms. Using highly validated antibodies is essential for research success and reproducible results.

Abcam also received ‘highly commended’ in ‘Recombinant Antibody Supplier of the Year’, acknowledging Abcam’s commitment to ending the reproducibility crisis by offering the most extensive catalog of recombinant antibodies on the market. Recombinant monoclonal antibodies offer many benefits over polyclonal antibodies, including batch-to-batch consistency, confirmed specificity, and ease of scalability.

CiteAb’s annual awards were launched in 2014 to celebrate the work and impact of companies and individuals in the global research reagent sector. The awards look to recognize life sciences providers making a significant impact to the industry in terms of antibody data, validation testing and reproducibility.

Markus Lusser, President, commented: “The CiteAb awards underscores our commitment to scientific excellence and the pivotal role that Abcam plays in the research community. We’re honored to be the first winner of the Antibody Supplier Succeeding in Genetics Research award, demonstrating our leadership in this innovative research area.”

Dr Andrew Chalmers, CEO and founder of CiteAb, comments: "Congratulations to Abcam for taking home the award for Antibody Supplier Succeeding in Genetics Research, and being named as Highly Commended in the Recombinant Antibody Supplier of the Year category! So much work goes on behind the scenes to make an impact like this and their dedication to advancing science and supporting the research community is great to see.  A fantastic achievement for the whole team!"

Rhys Williams, Head of Antibody Data at CiteAb, adds: “Genetics research is an area we have not recognised through our awards before, but which is essential for developing new therapies and advancing basic research. Abcam’s strong citation numbers for antibody products goes to show their support of scientists in this field.”

CiteAb’s annual awards were launched in 2014 to celebrate the work and impact of companies and individuals in the global research reagent sector. The awards look to recognize life sciences providers making a significant impact to the industry in terms of antibody data, validation testing and reproducibility.

Media contact: external.comms@abcam.com